TOPIGEN Pharmaceuticals Inc., a biopharmaceutical company specializing in innovative respiratory therapeutics, today announced that Dr. Paul Wotton, President and Chief Executive Officer, will present a corporate update at the Biotechnology Industry Organization's (BIO) 2006 Annual Chicago International Convention Business Forum on April 10, 2006 at 3:30 PM central time.
